Efficacy and Safety of Two‐Weekly Enfortumab Vedotin in Combination With Pembrolizumab for Advanced Urothelial Carcinoma

Ryunosuke Nakagawa, Kouji Izumi, Kazuki Toshima, Rikushi Fujimura, Tsukasa Yoshida, Takahiro Inaba, Shuhei Aoyama, Taiki Kamijima, Hiroshi Kano, Tomoyuki Makino, Renato Naito, Hiroaki Iwamoto, Hiroshi Yaegashi, Kazuyoshi Shigehara, Takahiro Nohara, Atsushi Mizokami
Asia-Pacific Journal of Clinical Oncology · Wiley · 2026-07-29 · DOI: 10.1111/ajco.70145

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles